Derek Chalmers
2021
Compensation breakdown
Option Awards | $7,950,174 |
---|---|
Salary | $570,062 |
Stock Awards | $1,665,680 |
Other | $10,869 |
Total | $10,196,785 |
Chalmers received $8M in option awards, accounting for 78% of the total pay in 2021.
Chalmers also received $570.1K in salary, $1.7M in stock awards and $10.9K in other compensation.
Rankings
In 2021, Derek Chalmers' compensation ranked 1,009th out of 12,415 executives tracked by ExecPay. In other words, Chalmers earned more than 91.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,009 | 92nd |
Manufacturing | 339 | 94th |
Chemicals And Allied Products | 113 | 95th |
Drugs | 96 | 95th |
Pharmaceutical Preparations | 64 | 96th |
Pay ratio
Derek Chalmers' Pay | $10,196,785 |
---|---|
Median Employee's Pay | $192,240 |
Pay Ratio | 53to 1 |
In 2021, the annual total compensation of Derek Chalmers was $10,196,785.
The annual total compensation of the median employee at Cara Therapeutics was $192,240.
The ratio of Derek Chalmers' pay to the pay of median employee was therefore 53 to one.
Chalmers' colleagues
We found five more compensation records of executives who worked with Derek Chalmers at Cara Therapeutics in 2021.
2021
Christopher Posner
Cara Therapeutics
Chief Executive Officer
2021
Frédérique Menzaghi
Cara Therapeutics
Chief Scientific Officer
2021
Joana Goncalves
Cara Therapeutics
Chief Medical Officer
2021
Scott Terrillion
Cara Therapeutics
General Counsel
2021
Thomas Reilly
Cara Therapeutics
Chief Financial Officer
News
April 22, 2022
April 23, 2021
April 22, 2020
April 24, 2019